Aggravation of hyperthyroidism after heterologous prime-boost immunization with inactivated and adenovirus-vectored SARS-CoV-2 vaccine in a patient with Graves' disease
American College of Rheumatology Guidance for COVID-19 vaccination, theoretical risk exists for AIIRD flare and potential risk for new onset autoimmunity